protein working mechanism of the world
shaping future drug design standards
next-generation drug innovation
- 1
- Platform
High-performance Research Platform for Mechanism of Target Proteins
Nobel Prize-level computational biology methods adapted to the research of ultra-large-scale biomolecular systems
0 1- High-performance Research Platform for Mechanism of Target Proteins
Multidisciplinary AI technologies and graph neural networks are integrated to construct a knowledge graph of drugs-targets-diseases, so as to mine new drug indications.
0 2- High-innovation Artificial Intelligence Platform for Mining New Disease Pathways
The intelligent contribution of professional drug research and development scientists " Design-Experiment-Optimization " cyclic iterative optimization.
0 3- High-level optimization platform of drug molecular design
Covering the full process of small molecule drug research and development, including virtual screening, structural design, fragment optimization, AI de novo drug generation, and molecular optimization.
0 4- High-intelligence Artificial Intelligence Small Molecule Drug Design Platform
World-leading generative artificial intelligence models to meet the research and development needs of various types of drugs, including antibodies, peptides, antibody-drug conjugates (ADCs), etc.
0 5- High-level Artificial Intelligence Macromolecular Drug Design Platform
AI-driven dynamic simulation and multimodal generation algorithms to meet the needs of molecular property prediction, molecular structure optimization, trimer modeling, etc.
0 6- High-performance Artificial Intelligence PROTAC Drug Design Platform
Based on the Directed Message Passing Neural Network (D-MPNN) technology to achieve rapid and accurate prediction of compound properties.
0 7- High-precision Artificial Intelligence Platform for Predicting ADMET Properties of Drugs
- 2
- Service
- 3
- News
2025-06-19
Recently, Professor Arieh Warshel, shareholder and Chief Scientist of Momed Biotech, was elected Honorary Chairman of the National Academy of Artificial Intelligence (NAAI).
2025-04-16
The emergence of variants of the SARS-CoV-2 virus poses challenges to the effectiveness of currently available vaccines and therapeutic antibodies. The research group led by Professor Bai Chen has analyzed the impact of mutations on the binding affinity between the spike protein of the novel coronavirus and neutralizing antibodies, antibodies from recovered patients, and artificially designed antibody mimetics by calculating changes in binding free energy. The study evaluates the differences between target sites on the spike protein for several antibodies. The results provided in this paper ma
2022-12-26
The Bai Chen Research Group Publishes Paper in the Biology Journal: "Explaining the Structure-Function Relationship of Three Types of G-Protein-Coupled Receptors from an Energetic Perspective"
2022-12-20
"In recent years, traditional drug design has required extensive research time and development costs. Computational methods have been widely used to enhance the efficacy and effectiveness of drug discovery and pipelines, leading to the approval of numerous new drugs. The White Morning Research Group published a review article in the International Journal of Molecular Sciences, focusing on the application and challenges of computational methods in assisting drug target identification, lead compound discovery, and optimization."
2022-11-05
- 4
- Partner
